Pharmaceuticals

Healthcare Startup One BioMed closes US$5M Series A Funding Round

SINGAPORE, July 10, 2019 /PRNewswire/ -- One BioMed Pte Ltd, a Singapore-based medical diagnostics company, announced today that it has closed aUS$5 million Series A financing round, led bySingapore-based Biopath Ventures and US-based ARCH Venture Partners, with Enterprise Singapore's investment ...

2019-07-10 19:12 3571

Hummingbird Bioscience Closes Extended Series A Financing To Advance Clinical Pipeline

SINGAPORE, July 10, 2019 /PRNewswire/ -- Hummingbird Bioscience, a Singapore founded biotech company focused on the discovery and development of novel antibody-based therapeutics, today announced the successful completion of an extended Series A financing round. The round was led by Heritas Capit...

2019-07-10 15:09 2880

ISTH Announces Launch Of New Global Education Initiative In Gene Therapy For Hemophilia

MELBOURNE, Australia, July 6, 2019 /PRNewswire/ --  The International Society on Thrombosis and Haemostasis (ISTH) is pleased to announce the official launch ofGene Therapy in Hemophilia: An ISTH Education Initiative. This landmark launch, the first of its kind in hemophilia, will take place duri...

2019-07-06 06:00 3411

NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical Study

LUND, Sweden, 4 July 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company has initiated the second part in its ongoing Phase Ia/b clinical study with KL1333, NeuroVive's candidate drug for chronic treatment of genetic mitochondri...

2019-07-04 21:05 8635

Gilead Sciences Announces Launch of Asia Pacific Rainbow Grant 2019

HONG KONG, July 3, 2019 /PRNewswire/ -- Gilead Sciences, Inc. today announced the launch of the 2019 Gilead Asia Pacific Rainbow Grant program, a grant initiative that supports community-led programs for people living with HIV in theAsia Pacific region. Non-governmental or advocacy organizations ...

2019-07-03 18:13 2769

A2A Pharmaceuticals Appoints Dr. Sotirios Stergiopoulos Chief Executive Officer

NEW YORK, July 3, 2019 /PRNewswire/ -- A2A Pharmaceuticals Inc. (A2A), a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents, today announced the appointment of Dr. Sotirios G. Stergiopoulos as President and Chief Executive Officer. He ha...

2019-07-03 04:28 2658

Asieris and Photocure Enter into a License Agreement for World-Wide Development and Commercialization of Cevira®

SHANGHAI and OSLO, Norway, July 2, 2019 /PRNewswire/ -- Asieris MediTech Co, Ltd (Asieris), aChina-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, and Photocure ASA (Photocure, PHO: OSE), The ...

2019-07-02 21:40 3009

Dachser India receives IATA CEIV Pharma certification

MUMBAI, India, July 2, 2019 /PRNewswire/ -- The International Airport Transport Association (IATA) recently awarded theMumbai and Hyderabad branches of Dachser India with the prestigious CEIV Pharma certification, recognizing the company for its excellence in transporting Life Science and Healthc...

2019-07-02 17:12 2855

CSL Behring Delivers on its Promise to Advance Bleeding Disorder Treatment Research by Supporting 16 Data Presentations at ISTH 2019

Novel real world evidence for AFSTYLA® and IDELVION® to be highlighted MELBOURNE, Australia, July 2, 2019 /PRNewswire/ -- Global biotherapeutics leaderCSL Behring announced today that the company will support the presentation of new data from its recombinant coagulation factor programs at this ...

2019-07-02 06:15 7974

Inaugural Winner of the Mundipharma Cancer Care Challenge Shines at Innovfest Unbound

SINGAPORE, June 28, 2019 /PRNewswire/ -- The five finalist teams of the inaugural 'Mundipharma Cancer Care Challenge' pitched their ideas on how to harness the power of technology to improve the lives of cancer patients to a panel of judges atSoutheast Asia's largest innovation festival, Innovfes...

2019-06-28 17:57 3570

Johnson & Johnson Innovation Opens JLABS @ Shanghai in Collaboration with Shanghai Pharma Engine Company Ltd.

SHANGHAI, June 27, 2019 /PRNewswire/ -- Johnson & Johnson Innovation, Division of Johnson & Johnson (China) Investment Ltd., today announced the opening of JLABS @Shanghai, the world's largest JLABS and the first in Asia Pacific. The 4,400-square-meter facility, located inShanghai's Zhangjiang...

2019-06-27 19:13 12109

Yisheng Biopharma Receives IND Clearance from China NMPA to Initiate Clinical Trial of YS-ON-001 in the Treatment of Advanced Solid Tumors

BEIJING, June 27, 2019 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, announced that it has received Investigational New Drug (IND) cleara...

2019-06-27 09:00 2865

Inovio Completes Enrollment of VGX-3100 Phase 3 Trial (REVEAL 1) for the Treatment of HPV-Related Cervical Pre-cancer

PLYMOUTH MEETING, Pennsylvania, June 26, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced the completion of target enrollment of 198 participants for its pivotal Phase 3 registration trial ("REVEAL 1") of VGX-3100, a novel DNA-based immunotherapy being tested to tre...

2019-06-26 21:47 3491
1 ... 179180181182183